TET3 - Tet3 tet methylcytosine dioxygenase 3 Gene
Species: Rattus norvegicus
Gene Type: protein coding
Gene ID: 680576
Summary
Predicted to enable methyl-CpG binding activity; methylcytosine dioxygenase activity; and zinc ion binding activity. Predicted to be involved in several processes, including DNA methylation or demethylation; cellular protein modification process; and oxidative demethylation. Predicted to be located in cytoplasm; female pronucleus; and male pronucleus. Predicted to be active in nucleus. Orthologous to human TET3 (tet methylcytosine dioxygenase 3). [provided by Alliance of Genome Resources, Apr 2022]
TET3 Products (5)
| mRNA | Protein | Name |
|---|---|---|
| XM_008763095.3 | XP_008761317.1 | methylcytosine dioxygenase TET3 isoform X1 |
| XM_039108717.1 | XP_038964645.1 | methylcytosine dioxygenase TET3 isoform X2 |
| XM_008763094.3 | XP_008761316.1 | methylcytosine dioxygenase TET3 isoform X1 |
| XM_001057850.7 | XP_001057850.2 | methylcytosine dioxygenase TET3 isoform X3 |
| XM_039108718.1 | XP_038964646.1 | methylcytosine dioxygenase TET3 isoform X4 |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
probable methylcytosine dioxygenase TET3 methylcytosine dioxygenase TET3 |
|
|
Related Agents
- Pre-clinical Phase
Pre-clinical Phase
Bioactive Molecules
(1)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-402410 | TETi76 | Inhibitor | 97.49% | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service